研究依达拉奉与丁苯酞联合治疗急性脑梗死的疗效

Study on the Efficacy of Edaravone Combined With Butylphthalide in the Treatment of Acute Cerebral Infarction

目的探究依达拉奉与丁苯酞联合治疗急性脑梗死的治疗效果。方法选取我院接收的120例急性脑梗死患者,随机分为对照组和观察组,各60例。对照组患者予以依达拉奉治疗,观察组予以依达拉奉与丁苯酞联合治疗。观察两组治疗效果。结果观察组与对照组治疗前的NISS评分对比,P>0.05,差异无统计学意义;治疗后观察组的NISS评分低于对照组,P<0.05,差异有统计学意义。两组患者总有效率对比,P<0.05,差异有统计学意义。结论依达拉奉与丁苯酞软胶囊联合治疗急性脑梗死,能够有效缓解患者脑梗症状。

Objective To explore the therapeutic effect of edaravone combined with butylphthalide in the treatment of acute cerebral infarction. Methods 120 patients with acute cerebral infarction in our hospital were selected, they were randomly divided into the control group and the observation group, each with 60 cases. The control group were treated with edaravone, and the observation group was treated with edaravone and butylphthalide. The effects of the two groups were observed. Results The comparison of NISS scores between the observation group and the control group before treatment was P 〉 0.05, and the difference was not statistically significant. After treatment, the NISS score of the observation group was lower than that of the control group, P 〈 0.05, the diference was statistically signifcant. The total efciency of the two groups was compared, P 〈 0.05, the diference was statistically signifcant. Conclusion Butylphthalide soft capsules combined with edaravone in treatment of acute cerebral infarction, can efectively alleviate the symptoms of patients with cerebral infarction.